nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—MAOA—endogenous depression	0.469	0.57	CbGaD
Naratriptan—HTR1A—endogenous depression	0.354	0.43	CbGaD
Naratriptan—MAOA—locus ceruleus—endogenous depression	0.00892	0.172	CbGeAlD
Naratriptan—HTR1F—forebrain—endogenous depression	0.00366	0.0704	CbGeAlD
Naratriptan—HTR1F—nervous system—endogenous depression	0.00199	0.0382	CbGeAlD
Naratriptan—HTR1F—central nervous system—endogenous depression	0.00191	0.0368	CbGeAlD
Naratriptan—HTR1F—Monoamine GPCRs—HTR2C—endogenous depression	0.00173	0.0146	CbGpPWpGaD
Naratriptan—HTR1A—Serotonin receptors—HTR7—endogenous depression	0.00162	0.0137	CbGpPWpGaD
Naratriptan—HTR1B—brainstem—endogenous depression	0.00155	0.0299	CbGeAlD
Naratriptan—MAOA—Dopamine metabolism—COMT—endogenous depression	0.00155	0.0131	CbGpPWpGaD
Naratriptan—HTR1D—Serotonin receptors—HTR2A—endogenous depression	0.00153	0.0129	CbGpPWpGaD
Naratriptan—HTR1F—brain—endogenous depression	0.00152	0.0292	CbGeAlD
Naratriptan—HTR1F—Monoamine GPCRs—HTR7—endogenous depression	0.00152	0.0128	CbGpPWpGaD
Naratriptan—HTR1F—Amine ligand-binding receptors—HTR1A—endogenous depression	0.00151	0.0127	CbGpPWpGaD
Naratriptan—HTR1D—brainstem—endogenous depression	0.0015	0.0289	CbGeAlD
Naratriptan—HTR1B—forebrain—endogenous depression	0.0015	0.0289	CbGeAlD
Naratriptan—HTR1B—Serotonin receptors—HTR2A—endogenous depression	0.00149	0.0126	CbGpPWpGaD
Naratriptan—HTR1F—Amine ligand-binding receptors—HTR2C—endogenous depression	0.00146	0.0123	CbGpPWpGaD
Naratriptan—HTR1D—forebrain—endogenous depression	0.00145	0.0279	CbGeAlD
Naratriptan—MAOA—Biogenic Amine Synthesis—COMT—endogenous depression	0.00138	0.0117	CbGpPWpGaD
Naratriptan—Almotriptan—MAOA—endogenous depression	0.00135	0.206	CrCbGaD
Naratriptan—Sumatriptan—MAOA—endogenous depression	0.0013	0.198	CrCbGaD
Naratriptan—HTR1F—Amine ligand-binding receptors—HTR7—endogenous depression	0.00127	0.0108	CbGpPWpGaD
Naratriptan—HTR1B—cardiovascular system—endogenous depression	0.00127	0.0244	CbGeAlD
Naratriptan—HTR1A—brainstem—endogenous depression	0.00125	0.0241	CbGeAlD
Naratriptan—HTR1D—cardiovascular system—endogenous depression	0.00123	0.0236	CbGeAlD
Naratriptan—HTR1A—forebrain—endogenous depression	0.00121	0.0233	CbGeAlD
Naratriptan—HTR1D—Monoamine GPCRs—HTR1A—endogenous depression	0.00115	0.00967	CbGpPWpGaD
Naratriptan—MAOA—brainstem—endogenous depression	0.00114	0.022	CbGeAlD
Naratriptan—HTR1A—Serotonin receptors—HTR2A—endogenous depression	0.00114	0.0096	CbGpPWpGaD
Naratriptan—HTR1B—Monoamine GPCRs—HTR1A—endogenous depression	0.00112	0.00947	CbGpPWpGaD
Naratriptan—HTR1D—Monoamine GPCRs—HTR2C—endogenous depression	0.00111	0.00934	CbGpPWpGaD
Naratriptan—MAOA—forebrain—endogenous depression	0.0011	0.0213	CbGeAlD
Naratriptan—HTR1B—Monoamine GPCRs—HTR2C—endogenous depression	0.00108	0.00914	CbGpPWpGaD
Naratriptan—MAOA—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.00108	0.00909	CbGpPWpGaD
Naratriptan—HTR1F—Monoamine GPCRs—HTR2A—endogenous depression	0.00106	0.00896	CbGpPWpGaD
Naratriptan—Eletriptan—HTR7—endogenous depression	0.00104	0.158	CrCbGaD
Naratriptan—MAOA—adrenal cortex—endogenous depression	0.00102	0.0197	CbGeAlD
Naratriptan—HTR1A—cardiovascular system—endogenous depression	0.00102	0.0197	CbGeAlD
Naratriptan—HTR1B—midbrain—endogenous depression	0.00099	0.0191	CbGeAlD
Naratriptan—Sumatriptan—HTR1A—endogenous depression	0.000983	0.15	CrCbGaD
Naratriptan—HTR1D—Monoamine GPCRs—HTR7—endogenous depression	0.00097	0.00818	CbGpPWpGaD
Naratriptan—HTR1D—Amine ligand-binding receptors—HTR1A—endogenous depression	0.000963	0.00813	CbGpPWpGaD
Naratriptan—HTR1D—midbrain—endogenous depression	0.000958	0.0184	CbGeAlD
Naratriptan—HTR1B—Monoamine GPCRs—HTR7—endogenous depression	0.000949	0.00801	CbGpPWpGaD
Naratriptan—HTR1B—Amine ligand-binding receptors—HTR1A—endogenous depression	0.000943	0.00796	CbGpPWpGaD
Naratriptan—MAOA—cardiovascular system—endogenous depression	0.000934	0.018	CbGeAlD
Naratriptan—HTR1D—Amine ligand-binding receptors—HTR2C—endogenous depression	0.00093	0.00785	CbGpPWpGaD
Naratriptan—HTR1B—Amine ligand-binding receptors—HTR2C—endogenous depression	0.000911	0.00769	CbGpPWpGaD
Naratriptan—HTR1F—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000893	0.00753	CbGpPWpGaD
Naratriptan—HTR1B—endocrine gland—endogenous depression	0.000869	0.0167	CbGeAlD
Naratriptan—MAOA—pituitary gland—endogenous depression	0.000827	0.0159	CbGeAlD
Naratriptan—HTR1A—Monoamine GPCRs—HTR2C—endogenous depression	0.000826	0.00696	CbGpPWpGaD
Naratriptan—HTR1D—Amine ligand-binding receptors—HTR7—endogenous depression	0.000815	0.00687	CbGpPWpGaD
Naratriptan—HTR1B—nervous system—endogenous depression	0.000814	0.0157	CbGeAlD
Naratriptan—HTR1A—adrenal gland—endogenous depression	0.000809	0.0156	CbGeAlD
Naratriptan—HTR1A—midbrain—endogenous depression	0.000799	0.0154	CbGeAlD
Naratriptan—HTR1B—Amine ligand-binding receptors—HTR7—endogenous depression	0.000798	0.00673	CbGpPWpGaD
Naratriptan—Eletriptan—HTR1A—endogenous depression	0.000796	0.121	CrCbGaD
Naratriptan—HTR1D—nervous system—endogenous depression	0.000788	0.0152	CbGeAlD
Naratriptan—HTR1B—central nervous system—endogenous depression	0.000783	0.0151	CbGeAlD
Naratriptan—HTR1D—central nervous system—endogenous depression	0.000758	0.0146	CbGeAlD
Naratriptan—MAOA—adrenal gland—endogenous depression	0.000739	0.0142	CbGeAlD
Naratriptan—MAOA—midbrain—endogenous depression	0.00073	0.014	CbGeAlD
Naratriptan—HTR1A—Monoamine GPCRs—HTR7—endogenous depression	0.000723	0.0061	CbGpPWpGaD
Naratriptan—MAOA—thyroid gland—endogenous depression	0.000713	0.0137	CbGeAlD
Naratriptan—HTR1A—endocrine gland—endogenous depression	0.000702	0.0135	CbGeAlD
Naratriptan—HTR1A—Amine ligand-binding receptors—HTR2C—endogenous depression	0.000694	0.00585	CbGpPWpGaD
Naratriptan—HTR1D—Monoamine GPCRs—HTR2A—endogenous depression	0.000679	0.00573	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Other—HTR7—endogenous depression	0.000673	0.00568	CbGpPWpGaD
Naratriptan—HTR1B—Monoamine GPCRs—HTR2A—endogenous depression	0.000665	0.00561	CbGpPWpGaD
Naratriptan—HTR1A—nervous system—endogenous depression	0.000657	0.0126	CbGeAlD
Naratriptan—MAOA—endocrine gland—endogenous depression	0.000641	0.0123	CbGeAlD
Naratriptan—HTR1A—central nervous system—endogenous depression	0.000632	0.0122	CbGeAlD
Naratriptan—HTR1B—brain—endogenous depression	0.000622	0.012	CbGeAlD
Naratriptan—HTR1A—cerebellum—endogenous depression	0.000618	0.0119	CbGeAlD
Naratriptan—Almotriptan—CYP2D6—endogenous depression	0.000613	0.0934	CrCbGaD
Naratriptan—HTR1A—Amine ligand-binding receptors—HTR7—endogenous depression	0.000608	0.00513	CbGpPWpGaD
Naratriptan—HTR1D—brain—endogenous depression	0.000602	0.0116	CbGeAlD
Naratriptan—MAOA—nervous system—endogenous depression	0.0006	0.0115	CbGeAlD
Naratriptan—MAOA—central nervous system—endogenous depression	0.000578	0.0111	CbGeAlD
Naratriptan—HTR1D—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000571	0.00481	CbGpPWpGaD
Naratriptan—MAOA—cerebellum—endogenous depression	0.000564	0.0109	CbGeAlD
Naratriptan—HTR1B—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000559	0.00471	CbGpPWpGaD
Naratriptan—HTR1A—Monoamine GPCRs—HTR2A—endogenous depression	0.000506	0.00427	CbGpPWpGaD
Naratriptan—HTR1A—brain—endogenous depression	0.000502	0.00966	CbGeAlD
Naratriptan—MAOA—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000488	0.00412	CbGpPWpGaD
Naratriptan—Eletriptan—CYP2D6—endogenous depression	0.000477	0.0728	CrCbGaD
Naratriptan—HTR1F—GPCRs, Other—HTR2A—endogenous depression	0.000472	0.00398	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000463	0.0039	CbGpPWpGaD
Naratriptan—MAOA—brain—endogenous depression	0.000458	0.00883	CbGeAlD
Naratriptan—HTR1A—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000426	0.00359	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.000393	0.00332	CbGpPWpGaD
Naratriptan—HTR1F—G alpha (i) signalling events—HTR1A—endogenous depression	0.000373	0.00314	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000351	0.00296	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000346	0.00292	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000334	0.00282	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000308	0.0026	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000298	0.00251	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000296	0.0025	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000293	0.00247	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.00029	0.00245	CbGpPWpGaD
Naratriptan—MAOA—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000287	0.00242	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000286	0.00241	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.00028	0.00236	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.00028	0.00236	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—ADM—endogenous depression	0.00028	0.00236	CbGpPWpGaD
Naratriptan—MAOA—Biological oxidations—CYP2D6—endogenous depression	0.000259	0.00219	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000251	0.00211	CbGpPWpGaD
Naratriptan—MAOA—Phase 1 - Functionalization of compounds—POMC—endogenous depression	0.000239	0.00202	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—HTR1A—endogenous depression	0.000238	0.00201	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000238	0.00201	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000238	0.00201	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—OXT—endogenous depression	0.000234	0.00198	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—CRH—endogenous depression	0.000234	0.00198	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—HTR1A—endogenous depression	0.000233	0.00197	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HTR1A—endogenous depression	0.000226	0.0019	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000221	0.00187	CbGpPWpGaD
Naratriptan—MAOA—Neuronal System—CACNB2—endogenous depression	0.00022	0.00186	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HTR2C—endogenous depression	0.000218	0.00184	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000217	0.00183	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000214	0.0018	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000209	0.00176	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000205	0.00173	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000204	0.00172	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000197	0.00166	CbGpPWpGaD
Naratriptan—MAOA—Biological oxidations—COMT—endogenous depression	0.000196	0.00166	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000194	0.00164	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000193	0.00163	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HTR7—endogenous depression	0.000191	0.00161	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000189	0.0016	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000187	0.00158	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000186	0.00157	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000183	0.00155	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000183	0.00154	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.00018	0.00152	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000179	0.00151	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000179	0.00151	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—ADM—endogenous depression	0.000179	0.00151	CbGpPWpGaD
Naratriptan—HTR1F—G alpha (i) signalling events—POMC—endogenous depression	0.000176	0.00149	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.000176	0.00148	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—ADM—endogenous depression	0.000175	0.00148	CbGpPWpGaD
Naratriptan—MAOA—Transmission across Chemical Synapses—COMT—endogenous depression	0.000174	0.00147	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000173	0.00146	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000172	0.00145	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000165	0.00139	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00016	0.00135	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000159	0.00134	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—ADM—endogenous depression	0.000158	0.00133	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000157	0.00132	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000153	0.00129	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—OXT—endogenous depression	0.00015	0.00126	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CRH—endogenous depression	0.00015	0.00126	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000147	0.00124	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CRH—endogenous depression	0.000147	0.00124	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—OXT—endogenous depression	0.000147	0.00124	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000146	0.00123	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR1A—endogenous depression	0.000144	0.00122	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—ADM—endogenous depression	0.000144	0.00121	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR1A—endogenous depression	0.000141	0.00119	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.00014	0.00118	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.00014	0.00118	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR2C—endogenous depression	0.000139	0.00118	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000137	0.00115	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR2C—endogenous depression	0.000136	0.00115	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—HTR2A—endogenous depression	0.000134	0.00113	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—ADM—endogenous depression	0.000133	0.00113	CbGpPWpGaD
Naratriptan—MAOA—Neuronal System—COMT—endogenous depression	0.000133	0.00113	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—OXT—endogenous depression	0.000132	0.00112	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CRH—endogenous depression	0.000132	0.00112	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000131	0.00111	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000128	0.00108	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR1A—endogenous depression	0.000128	0.00108	CbGpPWpGaD
Naratriptan—MAOA—Biological oxidations—POMC—endogenous depression	0.000127	0.00107	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2C—endogenous depression	0.000123	0.00104	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR7—endogenous depression	0.000122	0.00103	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CRH—endogenous depression	0.00012	0.00101	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—OXT—endogenous depression	0.00012	0.00101	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.00012	0.00101	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR7—endogenous depression	0.00012	0.00101	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR1A—endogenous depression	0.000116	0.000977	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—POMC—endogenous depression	0.000113	0.000951	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.000112	0.000947	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2C—endogenous depression	0.000112	0.000943	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CRH—endogenous depression	0.000112	0.000943	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—OXT—endogenous depression	0.000112	0.000943	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—POMC—endogenous depression	0.00011	0.000931	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.00011	0.000927	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR7—endogenous depression	0.000108	0.00091	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—POMC—endogenous depression	0.000107	0.000901	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2C—endogenous depression	0.000104	0.000877	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—ADM—endogenous depression	0.000101	0.000853	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—ADM—endogenous depression	9.9e-05	0.000835	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR7—endogenous depression	9.8e-05	0.000826	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	9.77e-05	0.000825	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—WASF2—endogenous depression	9.27e-05	0.000782	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—ADM—endogenous depression	9.18e-05	0.000774	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR7—endogenous depression	9.11e-05	0.000768	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—ADM—endogenous depression	8.99e-05	0.000758	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	8.97e-05	0.000756	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—WASF1—endogenous depression	8.89e-05	0.00075	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	8.78e-05	0.000741	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—HTR2A—endogenous depression	8.55e-05	0.000721	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ADM—endogenous depression	8.48e-05	0.000715	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CRH—endogenous depression	8.47e-05	0.000715	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—OXT—endogenous depression	8.47e-05	0.000715	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—POMC—endogenous depression	8.41e-05	0.00071	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	8.37e-05	0.000706	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—HTR2A—endogenous depression	8.37e-05	0.000706	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—OXT—endogenous depression	8.3e-05	0.0007	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CRH—endogenous depression	8.3e-05	0.0007	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR1A—endogenous depression	8.15e-05	0.000688	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR1A—endogenous depression	7.99e-05	0.000674	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2C—endogenous depression	7.88e-05	0.000664	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2C—endogenous depression	7.71e-05	0.000651	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—OXT—endogenous depression	7.69e-05	0.000649	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CRH—endogenous depression	7.69e-05	0.000649	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—HTR2A—endogenous depression	7.56e-05	0.000637	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—ADM—endogenous depression	7.54e-05	0.000636	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—OXT—endogenous depression	7.53e-05	0.000635	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CRH—endogenous depression	7.53e-05	0.000635	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR1A—endogenous depression	7.41e-05	0.000625	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TPH1—endogenous depression	7.32e-05	0.000617	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR1A—endogenous depression	7.25e-05	0.000612	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2C—endogenous depression	7.15e-05	0.000603	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CRH—endogenous depression	7.11e-05	0.000599	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—OXT—endogenous depression	7.11e-05	0.000599	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2C—endogenous depression	7e-05	0.000591	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR7—endogenous depression	6.9e-05	0.000582	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—HTR2A—endogenous depression	6.86e-05	0.000579	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—ADM—endogenous depression	6.85e-05	0.000578	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR1A—endogenous depression	6.84e-05	0.000577	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—POMC—endogenous depression	6.83e-05	0.000576	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR7—endogenous depression	6.75e-05	0.00057	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	6.69e-05	0.000564	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—POMC—endogenous depression	6.69e-05	0.000564	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2C—endogenous depression	6.61e-05	0.000557	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—HTR2A—endogenous depression	6.38e-05	0.000538	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—OXT—endogenous depression	6.32e-05	0.000533	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CRH—endogenous depression	6.32e-05	0.000533	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR7—endogenous depression	6.26e-05	0.000528	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR7—endogenous depression	6.13e-05	0.000517	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—POMC—endogenous depression	6.03e-05	0.000509	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—WASF2—endogenous depression	5.93e-05	0.0005	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2C—endogenous depression	5.87e-05	0.000496	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—WASF2—endogenous depression	5.81e-05	0.00049	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR7—endogenous depression	5.79e-05	0.000488	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—OXT—endogenous depression	5.74e-05	0.000484	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CRH—endogenous depression	5.74e-05	0.000484	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—WASF1—endogenous depression	5.68e-05	0.00048	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—WASF1—endogenous depression	5.57e-05	0.00047	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—TPH2—endogenous depression	5.55e-05	0.000468	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CACNB2—endogenous depression	5.55e-05	0.000468	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—POMC—endogenous depression	5.48e-05	0.000462	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—DPYD—endogenous depression	5.46e-05	0.00046	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ADM—endogenous depression	5.42e-05	0.000457	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2C—endogenous depression	5.33e-05	0.00045	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ADM—endogenous depression	5.31e-05	0.000448	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR7—endogenous depression	5.15e-05	0.000434	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—POMC—endogenous depression	5.09e-05	0.00043	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CACNA1C—endogenous depression	5.07e-05	0.000428	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—HTR2A—endogenous depression	4.83e-05	0.000408	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—HTR2A—endogenous depression	4.73e-05	0.000399	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR7—endogenous depression	4.67e-05	0.000394	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CRH—endogenous depression	4.54e-05	0.000383	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—OXT—endogenous depression	4.54e-05	0.000383	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—OXT—endogenous depression	4.45e-05	0.000375	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CRH—endogenous depression	4.45e-05	0.000375	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CYP2D6—endogenous depression	4.43e-05	0.000374	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—WASF2—endogenous depression	4.42e-05	0.000373	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—HTR2A—endogenous depression	4.39e-05	0.00037	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR1A—endogenous depression	4.37e-05	0.000369	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—HTR2A—endogenous depression	4.3e-05	0.000362	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR1A—endogenous depression	4.28e-05	0.000361	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—WASF1—endogenous depression	4.24e-05	0.000358	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2C—endogenous depression	4.23e-05	0.000356	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2C—endogenous depression	4.14e-05	0.000349	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—HTR2A—endogenous depression	4.05e-05	0.000342	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADM—endogenous depression	4.05e-05	0.000341	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—POMC—endogenous depression	3.86e-05	0.000325	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—POMC—endogenous depression	3.78e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR7—endogenous depression	3.7e-05	0.000312	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR7—endogenous depression	3.62e-05	0.000306	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—HTR2A—endogenous depression	3.6e-05	0.000304	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—POMC—endogenous depression	3.5e-05	0.000296	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—POMC—endogenous depression	3.43e-05	0.000289	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CRH—endogenous depression	3.39e-05	0.000286	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—OXT—endogenous depression	3.39e-05	0.000286	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—COMT—endogenous depression	3.36e-05	0.000283	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—HTR2A—endogenous depression	3.27e-05	0.000276	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—POMC—endogenous depression	3.24e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2C—endogenous depression	3.15e-05	0.000266	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—POMC—endogenous depression	2.88e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR7—endogenous depression	2.76e-05	0.000233	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—endogenous depression	2.61e-05	0.00022	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—endogenous depression	2.59e-05	0.000219	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—endogenous depression	2.54e-05	0.000214	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—endogenous depression	2.17e-05	0.000183	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—endogenous depression	2.07e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—endogenous depression	2.03e-05	0.000171	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—endogenous depression	1.93e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—endogenous depression	1.54e-05	0.00013	CbGpPWpGaD
